Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

National Cheng Kung University Hospital ( Site 3003), Tainan City

Hospital Aleman ( Site 2100), Buenos Aires

Hopitaux Universitaires de Geneve HUG ( Site 1701), Geneva

Alfred Health ( Site 0902), Melbourne

Inselspital Universitaetsspital Bern ( Site 1705), Bern

Royal Brisbane and Women s Hospital ( Site 0901), Herston

Sir Charles Gairdner Hospital ( Site 0903), Nedlands

Ospedale Regionale di Bellinzona e Valli ( Site 1703), Bellinzona

Kantonsspital Graubuenden ( Site 1704), Chur

Universitaetsspital Zurich ( Site 1700), Zurich

Kantonsspital St. Gallen ( Site 1702), Sankt Gallen

National Taiwan University Hospital ( Site 3000), Taipei

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023), New York

Chulalongkorn University ( Site 5001), Bangkok

Ramathibodi Hospital. ( Site 5002), Bangkok

Siriraj Hospital ( Site 5003), Bangkok

Lehigh Valley Hospital- Cedar Crest ( Site 0047), Allentown

Hospital Universitario Gregorio Maranon ( Site 0701), Madrid

Clinica Universitaria de Navarra ( Site 0704), Madrid

Hospital Ramon y Cajal ( Site 0702), Madrid

Institut Claudius Regaud IUCT Oncopole ( Site 0403), Toulouse

University of Florida-Health Cancer Center-Orlando ( Site 0015), Orlando

West Cancer Center - East Campus ( Site 0018), Germantown

Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0402), Saint-Herblain

Policlinico Le Scotte - A.O. Senese ( Site 1401), Siena

Sanford Cancer Center ( Site 0058), Sioux Falls

Sanford Fargo Medical Center ( Site 0059), Fargo

Centre Oscar Lambret ( Site 0401), Lille

Universitaetsklinikum Frankfurt ( Site 0306), Frankfurt am Main

HELIOS Dr. Horst Schmidt Kliniken Wiesbaden ( Site 0301), Wiesbaden

Centre Leon Berard ( Site 0405), Lyon

Robert Bosch GmbH ( Site 0307), Stuttgart

Mary Crowley Cancer Research Centers - Medical City Hospital ( Site 0049), Dallas

University of Colorado, Anschutz Cancer Pavilion ( Site 0007), Aurora

Istituto Nazionale Tumori Fondazione Pascale ( Site 1400), Napoli

Cedars Sinai Medical Center ( Site 0003), Los Angeles

City of Hope ( Site 0002), Duarte

Universitaetsklinikum Regensburg ( Site 0304), Regensburg

Institut Gustave Roussy ( Site 0400), Villejuif

University of California Davis Comprehensive Cancer Center ( Site 0005), Sacramento

Swedish Medical Center ( Site 0021), Seattle

Instituto Nacional de Cancerologia E.S.E ( Site 1102), Bogotá

Russian Oncological Research Center n.a. N.N. Blokhin ( Site 1604), Moscow

Arkhangelsk Clinical Oncological Dispensary ( Site 1600), Arkhangelsk

Leningrad Regional Oncology Center ( Site 1609), Saint Petersburg

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1610), Saint Petersburg

City Clinical Oncology Center ( Site 1608), Saint Petersburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1603), Kazan'

Oncologos del Occidente S.A. ( Site 1106), Pereira

Fundacion Valle del Lili ( Site 1101), Santiago de Cali

Rambam Medical Center ( Site 0602), Haifa

Centro Investigación del Cáncer James Lind ( Site 1203), Temuco

Chaim Sheba Medical Center ( Site 0600), Ramat Gan

Sourasky Medical Center ( Site 0603), Tel Aviv

Fundacion Arturo Lopez Perez ( Site 1201), Santiago

Pontificia Universidad Catolica de Chile ( Site 1202), Santiago

Hospital Clinico Universidad de Chile ( Site 1200), Santiago

Soroka Medical Center ( Site 0601), Beersheba

Hadassah Ein Kerem Medical Center ( Site 0604), Jerusalem

Rutgers Cancer Institute of New Jersey ( Site 0009), New Brunswick

University of Wisconsin Carbone Cancer Center ( Site 0017), Madison

Fundacion Favaloro para la Docencia e Investigacion Medica ( Site 2106), Ciudad Autonoma de Buenos Aires

Hospital Britanico de Buenos Aires ( Site 2109), Ciudad de Buenos Aires

Instituto de Oncologia de Rosario ( Site 2105), Rosario

CEMIC ( Site 2104), Buenos Aires

IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 2101), Caba

BC Cancer - Abbotsford ( Site 0200), Abbotsford

CancerCare Manitoba ( Site 0201), Winnipeg

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208), Hamilton

Sunnybrook Research Institute ( Site 0207), Toronto

Princess Margaret Cancer Centre ( Site 0202), Toronto

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0210), Montreal

CHU de Quebec Universite de Laval ( Site 0206), Québec

Fundacion Colombiana de Cancerologia Clinica Vida ( Site 1105), Medellín

Centre Antoine Lacassagne ( Site 0404), Nice

SRH Wald-Klinikum Gera GmbH ( Site 0309), Gera

Universitaetsklinikum Jena ( Site 0302), Jena

Istituto Clinico Humanitas Research Hospital ( Site 1402), Rozzano

Fondazione Policlinico Universitario A. Gemelli ( Site 1403), Roma

Asan Medical Center ( Site 1002), Songpagu

Seoul National University Hospital ( Site 1000), Seoul

Severance Hospital Yonsei University Health System ( Site 1001), Seoul

Hospital Clinic i Provincial ( Site 0703), Barcelona

Cambridge University Hospitals NHS Trust ( Site 0803), Cambridge

Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 0804), Leicester

Guy's Hospital ( Site 0806), London

Royal Marsden Hospital (Sutton) ( Site 0800), London

Christie NHS Foundation Trust ( Site 0805), Manchester